Senior Early Phase & Cell therapy Data Manager

The post holder will be working within the Early Phase & Cell Therapy Oncologyresearch team to ensure high quality data management in adherence to GCP, MHRA regulations, and institutional SOPs. This role involves working closely with clinical teams, researchers, and IT personnel to facilitate accurate data collection, secure data handling, and efficient trial management. The post holder will be responsible for maintaining Investigator Site Files, managing trial documentation, verifying source data, and preparing for audits and monitoring visits. They will lead departmental data management training, contribute to SOP development, and support continuous improvement initiatives.,

• Complete case report forms in a precise and timely manner, ensuring that all the relevant clinical data in the patient's medical notes and trial file is transcribed accurately.
• Liaise with the clinical team to organise and ensure that trial specific investigations are undertaken according to the protocol and obtain the results.
• Ensure the confidentiality of verbal, written and computerised information.
• Work in accordance with and ensure trials are managed to all regulatory requirements
• Lead on data management training for the department
• Supervise Junior Staff and data managers as required
  
  As part of Kings Health Partners, the Oncology and Haematology Clinical Trials (OHCT) team is made up of ninety plus staff members consisting of Research Nurses, Clinical Trial Practitioners, Clinical Trial Coordinators, data managers and the Safety & Support Team at Guys' and St Thomas' NHS Foundation Trust.
We work closely with the oncology and haematology medical teams to recruit patients to our trials and to ensure patients are monitored closely throughout. We have a large portfolio of Phase II and III trials; which are split into teams for specific tumour groups. We also have a team dedicated to early phase trials and run weekly early phase clinics in the Clinical Research Facility. We attract commercial and non-commercial trials, ranging from interventional drug or radiotherapy trials to observational studies. Our mission statement is 'Improving treatment choice, clinical care and outcomes for cancer patients through innovation, dedication and excellence in clinical trials'.